Northwest Biotherapeutics (NWBO) Gross Margin (2010 - 2013)

Northwest Biotherapeutics' Gross Margin history runs 4 years deep, the most recent figure standing at 100.0% for Q3 2013.

• In Q3 2013, Gross Margin changed N/A year-over-year to 100.0%; the TTM figure through Mar 2014 stood at 100.0% (changed 0.0% YoY), while the FY2013 annual figure was 100.0%, changed N/A from the prior year.
• Gross Margin for Q3 2013 stood at 100.0%, roughly flat from 100.0% in the prior quarter.
• The five-year high for Gross Margin was 100.0% in Q3 2010, with the low at 100.0% in Q3 2010.
• The 4-year median for Gross Margin is 100.0% (2010), against an average of 100.0%.
• Peak annual rise in Gross Margin reached 0 bps in 2011, while the deepest fall reached 0 bps in 2011.
• Northwest Biotherapeutics' Gross Margin stood at 100.0% in 2010, then changed by 0 bps to 100.0% in 2011, then changed by 0 bps to 100.0% in 2012, then changed by 0 bps to 100.0% in 2013.
• Business Quant data shows NWBO's Gross Margin at 100.0% in Q3 2013, 100.0% in Q2 2013, and 100.0% in Q1 2013.